Don’t miss out - Get your tickets early!

Join this FREE, 60-minute online webinar to gain access to insights and learn about ground breaking treatments to chronic mental health conditions.

This educational webinar will also address a range of specific needs for regional Australia.

Presented by Dr Jennifer Loughman and Peter Hunt AM.

Topic: Psychedelic-assisted therapies for mental illness: why innovation in treatment is needed now more than ever

Date: Wednesday 16 March 2022

Time: 7:55pm for 8:00pm start – 9:00pm (incl Q&A) (AEDT)

The presentation WILL BEGIN AT 8:00pm.

Location: Online. A link will be emailed to you with the viewing details

Don’t miss out - Get your tickets early!

More about medicinal psychedelic treatments:

Psychedelic-assisted treatments offer enormous potential in providing a meaningful alternative to current treatments for mental illness. PTSD is a debilitating condition that affects tens of millions of people worldwide, with many more trauma victims diagnosed with comorbid conditions such as depression, anxiety and eating disorders. In recent clinical trials, MDMA has been shown to produce reliable clinical improvements, restoring patient safety and self-agency even for individuals who have suffered with PTSD for many years, and for whom many treatments have failed.

The wave of clinical psychedelic research and regulatory support is rapidly building, with experts forecasting the availability of psychedelic-assisted treatments in the US and EU within the next 2 to 5 years, subject to positive clinical outcomes in large trials that are currently underway.

More about the presenters

Dr Jennifer Loughman
FRACGP MBBS(Hons) BSc DipEd CMgmt
General Practitioner & Entrepreneur

Dr Jennifer Loughman is a GP, having trained in medicine at University of Sydney and Biochemistry at the UNSW. She is a graduate of MMA’s first ever CPAT course, and provided advise in the science and health areas of the Prime Ministers department. She is cofounder of a start-up company in Canberra, bringing a new diagnostic into the health space.

She currently offers personalised, caring GP consultations in Canberra, having spent many years working around the country focused on Indigenous communities, regional communities plus less common gigs such as prisons and quarantine facilities, as well as running her own occupational health clinic.

Her serendipitous exploration into the therapy-assisted psychedelic space (via CPAT training with MMA) has opened up an exciting new field of medicine, as she finds this therapy compelling when compared to existing treatments and disease definitions. She will never look at mental health problems and solutions in the same way again and is looking toward helping general practitioners finding their role in this exciting, healing space.

Peter Hunt AM
B.Com, LL.B
Founder & Chair of Mind Medicine Australia

As an investment banker Peter Hunt AM advised local and multi-national companies and governments in Australia for nearly 35 years. He co-founded and was Executive Chairman of one of Australia’s leading investment banking advisory firms, Caliburn Partnership (now called Greenhill Australia) and continued as Chairman of the Firm after its sale to Greenhill Inc in 2009. Peter is an active philanthropist involved in funding, developing and scaling social sector organisations which seek to create a better and fairer world. Peter was made a member of the General Division of the Order of Australia in the Queen’s Birthday Honours List in 2010 for services to the philanthropic sector.

Support psychedelic research and therapy development

By donating to Mind Medicine Australia, you will be helping us to accelerate the availability and best practice of psychedelic-assisted psychotherapy in Australia. We are a small organisation doing big things – we need your support.

Please click here to make a tax-deductible donation.

Disclaimer

Mind Medicine Australia does not encourage or facilitate illegal use of psychedelics or plant medicines. MMA focus is focused on clinical and legal use only supported by the emerging science and legislative processes. Mind Medicine Australia reserves the right to record and publish webinars on various social media platforms. You agree that you will not discuss any names, locations or specific details of illegal use of psychedelics both verbally or via any written forms of communication via Mind Medicine Australia social media platforms (for example facebook, instagram and zoom private and public chat forms during the webinar). Breaches of these guidelines may result in not being able to participate in the event. We thank you for support and cooperation on these matters.

Mind Medicine Australia is focused specifically on the clinical application of medicinal psilocybin and medicinal MDMA for certain mental illnesses.